MYCOBACTERIAL SKIN ULCERS IN UGANDA: DESCRIPTION OF A NEW MYCOBACTERIUM (MYCOBACTERIUM BURULI).
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D001431:Bacteriological Techniques; D035843:Biomedical Research; D003933:Diagnosis; D005000:Ethionamide; D007538:Isoniazid; D051379:Mice; D009161:Mycobacterium; D009164:Mycobacterium Infections; D019911:Mycobacterium ulcerans; D010600:Pharmacology; D010619:Phenazines; D012883:Skin Ulcer; D013307:Streptomycin; D013882:Thiosemicarbazones; D014454:Uganda; D014756:Viomycin
D000636:Aminosalicylic Acids; D010619:Phenazines; D013882:Thiosemicarbazones; D010131:Aminosalicylic Acid; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin
AMINOSALICYLIC ACID; BACTERIOLOGICAL TECHNICS; CLINICAL RESEARCH; DIAGNOSIS; ETHIONIAMIDE; ISONIAZID; MICE; MYCOBACTERIUM INFECTIONS; PHARMACOLOGY; PHENAZINES; SKIN ULCER; STREPTOMYCIN; THIOSEMICARBAZONES; UGANDA; VIOMYCIN